14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ZVRA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Zevra Therapeutics, Inc. stock upgraded to Hold/Accumulate.
(Updated on May 17, 2024)

Hold candidate since May 17, 2024 PDF

The Zevra Therapeutics, Inc. stock price fell by -0.630% on the last day (Friday, 17th May 2024) from $4.76 to $4.73. During the last trading day the stock fluctuated 3.21% from a day low at $4.67 to a day high of $4.82. The price has fallen in 6 of the last 10 days and is down by -1.66% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -31 thousand shares and in total, 141 thousand shares were bought and sold for approximately $666.00 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $4.96 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -32.96% during the next 3 months and, with a 90% probability hold a price between $2.46 and $3.32 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ZVRA Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 5.11%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Zevra Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $4.84 and $4.80. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Zevra Therapeutics, Inc. stock

Zevra Therapeutics, Inc. finds support from accumulated volume at $4.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.150 between high and low, or 3.21%. For the last week the stock has had daily average volatility of 4.23%.

Our recommended stop-loss: $4.46 (-5.76%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 21 days ago.)

Trading Expectations (ZVRA) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Zevra Therapeutics, Inc. to open at $4.74, and during the day (based on 14 day Average True Range), to move between $4.51 and $4.95, which gives a possible trading interval of +/-$0.222 (+/-4.70%) up or down from last closing price. If Zevra Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 9.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.82 (1.90%) than the support at $4.58 (3.17%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Zevra Therapeutics, Inc. stock A Buy?

Zevra Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.671 Hold/Accumulate Upgraded

Predicted Opening Price for Zevra Therapeutics, Inc. of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
$4.74 ( 0.211%) $4.73

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ZVRA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.89 3.38 %
R2 4.83 2.17 %
R1 4.80 1.42 %
Current price: 4.73
Support S1 4.68 -1.00 %
S2 4.65 -1.75 %
S3 4.59 -2.96 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.16 9.09 %
R2 5.03 6.34 %
R1 4.82 1.90 %
Current price 4.73
Support S1 4.58 -3.17%
S2 4.52 -4.44%
S3 4.50 -4.86%

FAQ

What is the symbol for Zevra Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Zevra Therapeutics, Inc. is ZVRA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Zevra Therapeutics, Inc. Stock?
Zevra Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Zevra Therapeutics, Inc. Stock?
Zevra Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Zevra Therapeutics, Inc. Stock.

What's the current price of Zevra Therapeutics, Inc. Stock?
As of the end of day on the May 17, 2024, the price of an Zevra Therapeutics, Inc. (ZVRA) share was $4.73.

What is the 52-week high and low for Zevra Therapeutics, Inc. Stock?
The 52-week high for Zevra Therapeutics, Inc. Stock is $7.28 and the 52-week low is $3.89.

What is the market capitalization of Zevra Therapeutics, Inc. Stock?
As of the May 17, 2024, the market capitalization of Zevra Therapeutics, Inc. is 197.967M.

When is the next earnings date for Zevra Therapeutics, Inc.?
The upcoming earnings date for Zevra Therapeutics, Inc. is Aug 12, 2024.
Click to get the best stock tips daily for free!